Cye Cornelio retweeted
1/5
I think that the surprising findings from Lp(a)HORIZON should make us take a step back.
Pelacarsen lowered Lp(a) by ~78%, but MACE was unchanged (HR 1.02). No benefit even in those with very high Lp(a).
Perhaps most striking: no signal for fewer MIs - the most atherosclerosis-sensitive endpoint consistently reduced substantially in statin trials.
We still don't understand the mechanisms linking Lp(a) to clinical events. HORIZON makes that uncertainty hard to ignore.
Cye Cornelio retweeted
Replying to @venkmurthy
STREAM's "noninferior" was baked in
Max event-free time that could lose in 2 yrs: ~7.5 wks
Margin pre-set: 5.2 wks (~65% of max)
A perfect statin (0 MI/stroke/CV ☠️ events) gets ~3.5–4 wks
To fail non-inferiority statins would also have to ⬇️ non-CV ☠️
(which they don’t )
Cye Cornelio retweeted
💊 Quadruple GDMT for HFrEF at Cost Plus generic prices:
💵 $0.79/day · $23.83/mo · $290/yr
📉 ↓87% HF 🏨, ↓61% all-cause 🏨
🏥 Avoided hospital costs dwarf the drug cost
✅ Extraordinary value.
🎯 Get every eligible patient on all 4! ❤️
#GDMT @costplusdrugs @mcuban
Excited to be moderating the Annual HF & CM Pecha Kucha again at #AHA26. This year’s session: Welcome to Cardio-Oncology 2.0, today at 1:30pm. Come watch @JLHarrington_MD defend her title against a competitive lineup! 🏆#ScientificSessions26
1
3
155
Congrats to @DrGuptaD! 🏆 Key takeaways from her show-stopping 🗣️on the CV complications of radiation therapy.
☢️ “Radiation waits decades to see if we’re still watching”
☢️ The RR of CAD ⬆️ 7.4% per Gy of mean heart dose
☢️ Get the mean heart dose, stratify risk, and optimize
Cye Cornelio retweeted
💔⏳ HF won't wait — neither should you
Start all four pillars early in #HFrEF
🛠️ ARNI ➕ 🛡️ β-blocker➕ 🧪 MRA ➕ 🍬 SGLT2i
Every day of delay is a day of lost benefit
Plus 312 extra lives that could have been saved
#GDMT #CardioTwitter
Rise and shine, #AHA25 Come check out the Heart Failure/Cardiomyopathy Annual Pecha Kucha! ⏰8AM / 📍260-262. This year, Pecha Kucha Says: It`s All About Cardiovascular-Kidney Metabolic Health. Join us to continue the conversation on CKM as speakers contend to earn your vote! 🏆
1
65
Congratulations 👏 to @JLHarrington_MD on winning our 7th Annual Pecha Kucha with her fantastic presentation,PREVENT the Perfect Storm: Managing Metabolic Syndrome! #AHA25
1
47
Cye Cornelio retweeted
Pecha Kucha Sunday 8AM Room 261 @AHAScience on #CKM Syndrome #AHA25 #CardioX @DrMarthaGulati @AnastasiaSMihai @iamritu @hvanspall @Drroxmehran @Pooh_Velagapudi @hmartinjulien @SVRaoMD @mmamas1973 @purviparwani @rblument1 @pabeda1 @DavidWienerMD @KTamirisaMD & vote for Savage 😜
Cye Cornelio retweeted
VESALIUS-CV trial: Adding evolocumab to LLRx significantly cuts LDL-C and lowers the risk of CV death/MI/ischemic stroke/ischemia-driven revasc at 4.5 years vs. placebo in high-risk patients without a prior MI or stroke. #AHA25 View the slides here: clinicaltrialresults.org/wp-…
Cye Cornelio retweeted
Diuretics in AHF:
1.loop diuretics,if refractory> 2.combine with thiazide,if refractory>
3.add dopamine,dobutamine, milrinone
4. Ultrafiltration or hemodialysis(coexist renal failure)
In case of low k+>add spironolactone
In case of alkalosis>add acetazolamide
From Braunwald
Cye Cornelio retweeted
Join Dr. @AminYehyaMD and team as they shed light on the latest #epICD recommendations, examining everything from clinical trials to real-world scenarios, patient disparities, & future methodologies. Discover who could benefit most from an ICD. jacc.org/doi/10.1016/j.jchf.…
#JACCHF #GDMT #HFrEF @AndrewJSauer @BiykemB @SanaAlkhatib9
Cye Cornelio retweeted
In pts with HFrEF and hyperkalemia (K>5 mEq/L), sodium zirconium cyclosilicate improves optimizing the use of MRA and K levels, reduces risk of hyperkalemia and need to discontinue MRA. Slides from REALIZE-K trial presented here: clinicaltrialresults.org/wp-…
Cye Cornelio retweeted
Sacubitril-Valsartan effective in reducing risk of cardiotoxicity in high risk pts undergoing anthracycline chemotherapy, 18% absolute risk reduction with Sacubitril-Valsartan vs placebo. Dr. Marcely Gimenes Bonatto shares results of SARAH trial
clinicaltrialresults.org/wp-…
Don’t miss @noshreza battle to defend her title in the 6th Annual Pecha Kucha Heart Failure Session at #AHA24! Join us for an entertaining session on infection, inflammation, and heart failure! 🦠🫀Who will be this year’s champion?🏆 @MarkDrazner @SherylChow
Congratulations to @EricAdler17 on winning this year’s Pecha Kucha Heart Failure session! Thanks to all our speakers for a great session!
1
39
Cye Cornelio retweeted
In the CLEAR randomized trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse cardiovascular events over a median follow-up period of 3 years. Full trial results: nej.md/4i2U6dV
Cye Cornelio retweeted
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes #AHA24| New England Journal of Medicine nejm.org/doi/full/10.1056/NE…
The complexities of telehealth in heart failure management highlighted by @colleenkmac at #AHA24. We need to develop interventions to overcome systemic barriers in the digital divide.
3
135
Happening now at #AHA Optimizing Heart Failure Through a Multidisciplinary approach! Learning more about international efforts to adopt GDMT from @batallah08 who established the FIRST pharmacist-led optimization clinics in the Middle East Gulf Region! #GDMTworks







































